Connect with us

Health

9.5m children received no routine vaccine in 57 countries in 2025

info

Published

on

Width 800 1.jpg

Gavi, the Vaccine Alliance, says 9.5 million children in 57 supported countries received no routine vaccine in 2025, despite gains in global immunisation.

The figure, described as the number of “zero-dose” children, was contained in Gavi’s 2025 Annual Progress Report, which reviewed the alliance’s 2021-2025 strategic period.

Gavi defines zero-dose children as infants who have not received the first dose of a diphtheria, tetanus and pertussis-containing vaccine by the end of their first year.

Number falls from 2021 peak

According to the report, the number of zero-dose children in 2025 was 600,000 lower than in 2024 and 25 per cent lower than the peak recorded in 2021 following disruptions to routine immunisation caused by the COVID-19 pandemic.

However, the figure remained four per cent above the 2019 baseline, partly because of continued growth in the number of children being born.

Gavi said children living in fragile, conflict-affected and humanitarian settings remain among those most likely to be missed by immunisation programmes.

PT WHATSAPP CHANNEL
Dangote Refinery AD

Nigeria remains one of the countries with the highest number of zero-dose children. UNICEF estimated that about 2.2 million Nigerian children had never received a routine vaccine in 2025, the highest number in Africa.

Nigeria records gains in targeted areas

The report highlighted Nigeria, Ethiopia and Pakistan among countries where emerging data showed stronger immunisation coverage gains in sub-national areas that received greater Gavi focus and investment during the 2021-2025 period.

Gavi said the findings underscored the value of targeted, equity-focused investments in reaching communities that are being missed by routine immunisation.

The report also identified Nigeria among countries covered by Gavi’s Zero-Dose Learning Hubs, which examined what works and what does not in identifying and reaching zero-dose and under-immunised children.

The findings from Nigeria, Bangladesh, Mali and Uganda highlighted several issues, including gender-related barriers to immunisation.

73m children immunised in 2025

Despite the number of zero-dose children, Gavi said more than 73 million children were immunised through routine programmes with its support in 2025.

More than 351 million children were immunised during the 2021-2025 strategic period, “exceeding Gavi’s target of 300 million children.”

“By end 2025, Gavi-supported countries had immunised more than 1.3 billion unique children with Gavi support since 2000, exceeding our Investment Opportunity 2021-2025 commitment of more than 1.1 billion children immunised by 2025,” it noted.

Gavi said vaccination averted more than 2.2 million future deaths in 2025, bringing the total number of future deaths averted through its supported vaccination programmes to more than 7.8 million during the 2021-2025 period.

Generated economic benefits

The report said immunisation programmes generated more than $30 billion in economic benefits for Gavi-supported countries in 2025, the highest amount recorded in a single year.

The benefits were calculated from the costs of illness averted, including medical and associated costs, caretaker wages and productivity losses resulting from disability or death.

Gavi said the programmes generated more than $104 billion in economic benefits between 2021 and 2025 and more than $308 billion between 2000 and 2025.

Countries also contributed a record $301 million towards the co-financing of Gavi-supported vaccines in 2025, an 18 per cent increase from 2024.

About 80 per cent of the contribution came from domestic resources, while “approximately 20 per cent from low-interest loans from the World Bank.”

Gavi said countries had contributed a total of $2.2 billion towards vaccine co-financing since the policy was introduced in 2008.

More children

For its 2026 to 2030 strategic period, Gavi said it aims to protect another 500 million children through immunisation and avert between eight million and nine million future deaths.

READ ALSO:New TB vaccines could save 7.3m lives by 2050 – Gavi 

The Alliance also targets more than $100 billion in economic benefits during the period. Gavi said it would place greater emphasis on reaching zero-dose and under-immunised children while strengthening the sustainability of national immunisation programmes.

In her comments, Gavi Chief Executive Officer, Sania Nishtar, said the results showed that immunisation generates benefits beyond preventing disease. “However, when it comes to immunisation we know that the return on investment extends far beyond health to supporting sustainable, inclusive economic growth,” Ms Nishtar said.

WHO Director-General, Tedros Ghebreyesus, also said immunisation delivers massive gains in lives saved and diseases prevented, but also in terms of economic benefits.

“Countries understand that the cost of failing to vaccinate is far too great, while the benefits extend across families, communities, economies and future generations,” Mr Ghebreyesus was quoted to have said.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

AMR Week: Artists, health experts use arts to raise awareness about drug resistance

info

Published

on

Arts exhibition at Microbe Madness 2.0 scaled.jpg

Artists and health experts are using art, storytelling and interactive activities to raise awareness about antimicrobial resistance (AMR).

AMR occurs when bacteria, viruses, fungi and parasites no longer respond to medicines used to treat infections, making diseases more difficult to manage.

The awareness event, Microbe Madness 2.0, organised by the Art for Health Initiative (AHI), was held in Lagos on Wednesday, the first day of the 2026 World AMR Awareness Week, observed from 18 to 24 November.

Olayinka Badmus and Media EIS Frontliners
Olayinka Badmus and Media EIS Frontliners

The event themed: One Action for our Future, featured exhibitions by artists exploring AMR and other health-related themes, including a mental health exhibition showcasing works produced by artists who participated in an earlier workshop organised by AHI.

It also featured spoken-word performances by Ruth Mahogany, music by Nanya ljeh and Paragon, and interactive games designed to help participants understand AMR and how everyday actions can help prevent it.

Philip Osun
Philip Osun

Antibiotics misuse

Delivering the keynote address at the event, Philip Osun, a clinical microbiologist at the Lagos University Teaching Hospital (LUTH), warned against the indiscriminate use of antibiotics.

PT WHATSAPP CHANNEL
Dangote Refinery AD

Mr Osun said antibiotics are designed to treat bacterial infections and are ineffective against viral illnesses such as most common colds.

“Don’t rush to the chemist and say I need antibiotics,” Mr Osun said, urging people to seek medical advice rather than self-medicate.

He also cautioned against taking antibiotics prescribed for others, sharing medicines or starting, stopping or changing treatment without professional advice.

According to him, antimicrobial resistance occurs when germs develop mechanisms to overcome medicines designed to treat them, making infections difficult to manage.

Mr Osun said the consequences could include prolonged illness, expensive treatment and increased pressure on families and healthcare facilities.

The World Health Organisation (WHO), in a statement to mark the start of World AMR Awareness Week, said bacterial AMR was associated with an estimated 4.7 million deaths globally in 2021, with sub-Saharan Africa recording the highest rates of AMR-associated mortality.

The WHO said tackling resistance requires action across human, animal, plant and environmental health, noting that inappropriate use of antimicrobials, poor infection prevention, inadequate water and sanitation, and unsafe waste disposal contribute to its spread.

Chidera Aneke
Chidera Aneke

Preventing infections

The microbiologist encouraged Nigerians to prevent infections through regular handwashing, vaccination, safe food and water practices, proper wound care and good hygiene.

He said preventing infections reduces the need for antimicrobials and helps limit the development and spread of resistance.

Mr Osun also explained the One Health approach, noting that human, animal and environmental health are interconnected.

He said antimicrobial resistance is not only a human health problem but also involves animals and the environment, requiring coordinated efforts to prevent infections and reduce inappropriate antimicrobial use.

Using art to communicate health messages

Speaking about the initiative, Chidera Aneke, founder of AHI and a Media EIS Frontliner, said AMR remains poorly understood despite its growing impact.

READ ALSO: World Antibiotic Awareness Week: New health challenge emerges with antibiotics misuse

Ms Aneke said the organisation uses art and creative activities to communicate health information in ways people can relate to and remember.

She said the initiative plans to make Microbe Madness an annual event and involve more creatives in public health awareness.

“With more funding, we can make this a yearly event,” she said, adding that the initiative wants people to learn about health issues through activities that are enjoyable and interactive, rather than only workshops and seminars.

The event also had in attendance Olayinka Badmus, Resident Adviser for the Media EIS Fellowship and Technical Director at Afrihealth for Social Development and Impact (ASDI).

It was organised with DRASA Health Trust as a technical partner and support from the Yemisi Shyllon Museum of Art and BNL Healthcare Limited.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Health

AMR: Pharmacist urges Nigeria to implement policies to curb drug resistance

info

Published

on

20261119 113031 scaled.jpg

Nigeria needs to translate its antimicrobial resistance (AMR) policies into action to curb the growing threat of drug-resistant infections, a pharmacist has said.

Folashade Lawal, managing director and chief executive officer of Victory Drugs, said the country had developed policies and guidelines to address AMR but faced challenges implementing them across healthcare facilities and communities.

“The challenge now lies not in planning but in implementation,” Ms Lawal said on Thursday while delivering the ninth Ladipo Mobolaji Abisogun-Afodu Annual Lecture in Pharmacy at the College of Medicine, University of Lagos.

The lecture, titled Addressing Antimicrobial Stewardship in Nigeria: Current Perspectives and Future Imperatives, was held during the 2026 World Antimicrobial Resistance Awareness Week, observed from 18 to 24 November.

Folashade Lawal, Pharmacist and Founder of Victory Drugs

Policies, implementation gaps

Nigeria’s first National Action Plan on Antimicrobial Resistance covered 2017 to 2022. The plan sought to reduce, prevent and slow the emergence of resistant organisms through awareness, surveillance, infection prevention and control, responsible antimicrobial use, and research.

PT WHATSAPP CHANNEL

An assessment of its implementation found that only 44 per cent of the plan’s activities had been completed, highlighting gaps in coordination, funding and implementation across sectors.

Dangote Refinery AD

Nigeria subsequently launched its second One Health National Action Plan on AMR, covering 2024 to 2028, with six strategic objectives, including stronger governance, surveillance, public awareness, infection prevention and control, responsible antimicrobial use, and research and capacity development.

Ms Lawal said antimicrobial stewardship activities are yet to become routine in many healthcare institutions, despite the country’s policy commitments.

She called for stronger enforcement of regulations governing antimicrobial sales, sustainable funding for stewardship programmes at federal, state and institutional levels, improved access to diagnostic services and laboratory infrastructure, and the establishment of stewardship programmes across healthcare facilities.

She also urged the government to strengthen antimicrobial consumption monitoring, invest in workforce development and research, and expand public awareness of responsible antimicrobial use.

In his welcome remarks, the Dean of the Faculty of Pharmacy, University of Lagos, Sunday Adesegun, said antimicrobial resistance threatened the effective treatment of infectious diseases and could reverse gains made in modern medicine.

He said Nigeria continued to grapple with self-medication, indiscriminate access to antibiotics, inadequate infection prevention and control, and gaps in antimicrobial resistance surveillance.

“Antimicrobial stewardship is not merely a professional responsibility; it is a collective obligation to safeguard public health,” Mr Adesegun said, urging stakeholders to move beyond awareness to concrete action.

Folashade Lawal, Pharmacist and Founder of Victory Drugs

Growing threat

Ms Lawal described antimicrobial resistance as a “silent pandemic” that steadily undermines the effectiveness of medicines used to treat infections.

She said bacterial antimicrobial resistance was associated with approximately 4.7 million deaths globally in 2021, including 1.14 million deaths directly attributable to resistant infections.

In Nigeria, she cited estimates that antimicrobial resistance was directly responsible for 50,500 deaths and associated with about 227,000 deaths in 2021.

She warned that resistance threatens not only the treatment of common infections but also modern medical procedures, including surgery, cancer treatment, organ transplantation, neonatal care and intensive care, which depend on effective antimicrobials.

Ms Lawal identified self-medication, inappropriate prescribing and dispensing, unrestricted access to antibiotics, weak regulatory enforcement, inadequate infection prevention and control, and limited diagnostic capacity as major drivers of antimicrobial resistance.

She said inadequate laboratory services often leave healthcare professionals relying on empirical treatment without diagnostic confirmation.

Pharmacists’ role

Ms Lawal urged community pharmacists to refuse inappropriate antibiotic supply without valid prescriptions, source medicines from regulated suppliers, counsel patients on proper use and refer patients for medical care when necessary.

She said hospital pharmacists should support stewardship through prescription reviews, monitoring antimicrobial consumption and collaborating with other healthcare professionals to optimise treatment.

She also called for antimicrobial stewardship to be integrated into pharmacy education and for stronger collaboration among healthcare professionals.

The chairman of the occasion, Olumide Akintayo, a former president of the Pharmaceutical Society of Nigeria, said healthcare professionals, government and other stakeholders had contributed to inappropriate antimicrobial use.

He called for urgent action, including improved regulation, public awareness and responsible professional practice.

He also noted that Nigeria would host the fifth Global High-Level Ministerial Conference on Antimicrobial Resistance in December.

READ ALSO: Plateau pharmacists campaign against child marriage, urge girl-child education

Research grant

At the event, Olusegun Ajala of the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Lagos, won the 2026 Ladipo Mobolaji Abisogun-Afodu Research Grant Award in Pharmacy and received N2.7 million.

His proposal, titled Development of a Psidium guajava-Based Antibiotic Adjuvant for Restoring the Susceptibility of Multidrug-Resistant Bacteria to Conventional Antibiotics, was selected as the winning research proposal.

Deborah Ogundemuren and colleagues from the Department of Pharmaceutics and Pharmaceutical Technology came second with a proposal to develop a bioactive, sprayable hydrogel for postpartum perineal wound care as an antibiotic-sparing strategy.

Osideko Oluwaseun and colleagues from the Department of Pharmaceutical Chemistry came third with a proposal on the chemical standardisation and antibacterial characterisation of fermented maize mash supernatant, known as omidun, produced using different fermentation strategies.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Trending